Chemours Company (The) (CC) : 2 investment research analysts covering Chemours Company (The) (CC) have an average price target of $13.5 for the near short term. The highest target price given by the Brokerage Firm to the stock is $17 and the lowest target is $10 for the short term. Analysts expect the variance to be within $4.95 of the average price.
Chemours Company (The) (CC) : Zacks Investment Research ranks Chemours Company (The) (CC) as 1, which is a Strong Buy recommendation. 2 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 more believe that the stock has more downside risks, hence they propose a Strong Sell. A total of 1 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 4 research analysts is 2.5, which indicates as a Buy.
Also, In the latest statement by the brokerage house, Citigroup maintains its outlook on Chemours Company (The) (NYSE:CC). The current rating of the shares is Neutral, according to the research report released by the firm. The brokerage firm raises the price target from $9 per share to $11 per share. The rating by the firm was issued on August 11, 2016.
Chemours Company (The) (NYSE:CC): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $13.30 and $13.07 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $13.58. The buying momentum continued till the end and the stock did not give up its gains. It closed at $13.47, notching a gain of 2.12% for the day. The total traded volume was 1,709,435 . The stock had closed at $13.19 on the previous day.
The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, general industrial, and mining and oil refining. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands, including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands, including Suva, ISCEON, Freon, Opteon, Teflon, Tefzel, Viton, Krytox, Formacel, Dymel, FM 200, Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands, including Virkon and Oxone. The Companys products include titanium dioxide, refrigerants, industrial fluoropolymer resins, sodium cyanide, sulfuric acid and aniline.